Frequencies for first 10,000 rows of indi_pt variable in indi2007q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- 5Q-SYNDROME | 1 0.01 0.01 ABDOMINAL DISCOMFORT | 1 0.01 0.02 ABDOMINAL INFECTION | 2 0.02 0.04 ABDOMINAL PAIN | 9 0.09 0.13 ABDOMINAL PAIN LOWER | 1 0.01 0.14 ABDOMINAL PAIN UPPER | 8 0.08 0.22 ABNORMAL BEHAVIOUR | 2 0.02 0.24 ABORTION | 1 0.01 0.25 ABORTION INDUCED | 5 0.05 0.30 ACARODERMATITIS | 1 0.01 0.31 ACCIDENTAL EXPOSURE | 6 0.06 0.37 ACNE | 33 0.33 0.70 ACQUIRED IMMUNODEFICIENCY SYNDROME | 16 0.16 0.86 ACROMEGALY | 1 0.01 0.87 ACTINIC KERATOSIS | 1 0.01 0.88 ACUTE LYMPHOCYTIC LEUKAEMIA | 23 0.23 1.11 ACUTE MYELOID LEUKAEMIA | 8 0.08 1.19 ACUTE MYELOID LEUKAEMIA RECURRENT | 2 0.02 1.21 ACUTE MYOCARDIAL INFARCTION | 4 0.04 1.25 ACUTE PSYCHOSIS | 2 0.02 1.27 ACUTE SINUSITIS | 4 0.04 1.31 ACUTE TONSILLITIS | 1 0.01 1.32 ADENOCARCINOMA PANCREAS | 5 0.05 1.37 ADENOID CYSTIC CARCINOMA | 2 0.02 1.39 ADJUSTMENT DISORDER | 4 0.04 1.43 ADRENOCORTICAL CARCINOMA | 1 0.01 1.44 AFFECTIVE DISORDER | 6 0.06 1.50 AGGRESSION | 2 0.02 1.52 AGITATION | 10 0.10 1.62 AGRANULOCYTOSIS | 1 0.01 1.63 AKATHISIA | 1 0.01 1.64 ALCOHOL WITHDRAWAL SYNDROME | 1 0.01 1.65 ALCOHOLIC LIVER DISEASE | 4 0.04 1.69 ALCOHOLISM | 4 0.04 1.73 ALLERGIC BRONCHITIS | 1 0.01 1.74 ALLERGIC SINUSITIS | 1 0.01 1.75 ALLERGY TO CHEMICALS | 1 0.01 1.76 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 1 0.01 1.77 ALOPECIA | 1 0.01 1.78 ALPHA-1 ANTI-TRYPSIN DEFICIENCY | 1 0.01 1.79 ANAEMIA | 12 0.12 1.91 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 1.92 ANAEMIA OF MALIGNANT DISEASE | 5 0.05 1.97 ANAEMIA PROPHYLAXIS | 6 0.06 2.03 ANAESTHESIA | 24 0.24 2.27 ANAESTHETIC PREMEDICATION | 2 0.02 2.29 ANAL FISTULA | 1 0.01 2.30 ANALGESIA | 15 0.15 2.45 ANALGESIC THERAPY | 1 0.01 2.46 ANAPHYLACTIC REACTION | 2 0.02 2.48 ANGER | 1 0.01 2.49 ANGINA PECTORIS | 20 0.20 2.69 ANGINA UNSTABLE | 1 0.01 2.70 ANGIOGRAM | 1 0.01 2.71 ANGLE CLOSURE GLAUCOMA | 4 0.04 2.75 ANKYLOSING SPONDYLITIS | 26 0.26 3.01 ANOREXIA | 5 0.05 3.06 ANTACID THERAPY | 3 0.03 3.09 ANTI-INFECTIVE THERAPY | 27 0.27 3.36 ANTIBIOTIC PROPHYLAXIS | 9 0.09 3.45 ANTICOAGULANT THERAPY | 14 0.14 3.59 ANTIDEPRESSANT THERAPY | 3 0.03 3.62 ANTIDIARRHOEAL SUPPORTIVE CARE | 1 0.01 3.63 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 3.64 ANTIFUNGAL PROPHYLAXIS | 11 0.11 3.75 ANTIINFLAMMATORY THERAPY | 8 0.08 3.83 ANTIOESTROGEN THERAPY | 1 0.01 3.84 ANTIPLATELET THERAPY | 4 0.04 3.88 ANTIPYRESIS | 2 0.02 3.90 ANTITHROMBIN III DEFICIENCY | 2 0.02 3.92 ANTITUSSIVE THERAPY | 2 0.02 3.94 ANTIVIRAL PROPHYLAXIS | 7 0.07 4.01 ANXIETY | 85 0.85 4.86 ANXIETY DISORDER | 7 0.07 4.93 AORTIC ANEURYSM | 1 0.01 4.94 AORTIC VALVE REPLACEMENT | 3 0.03 4.97 APLASIA PURE RED CELL | 2 0.02 4.99 APLASTIC ANAEMIA | 2 0.02 5.01 ARRHYTHMIA | 11 0.11 5.12 ARRHYTHMIA SUPRAVENTRICULAR | 1 0.01 5.13 ARTERIAL DISORDER | 1 0.01 5.14 ARTERIAL THROMBOSIS LIMB | 1 0.01 5.15 ARTERIOGRAM CAROTID | 1 0.01 5.16 ARTERIOSCLEROSIS | 1 0.01 5.17 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 5.18 ARTERIOSCLEROSIS OBLITERANS | 3 0.03 5.21 ARTERITIS | 1 0.01 5.22 ARTHRALGIA | 38 0.38 5.60 ARTHRITIS | 61 0.61 6.21 ARTHRITIS REACTIVE | 1 0.01 6.22 ARTHROPATHY | 3 0.03 6.25 ARTHROPOD BITE | 2 0.02 6.27 ASCITES | 1 0.01 6.28 ASPERGILLOMA | 5 0.05 6.33 ASTEATOSIS | 1 0.01 6.34 ASTHENOPIA | 1 0.01 6.35 ASTHMA | 150 1.50 7.85 ASTHMA PROPHYLAXIS | 1 0.01 7.86 ASTROCYTOMA | 2 0.02 7.88 ATRIAL FIBRILLATION | 40 0.40 8.28 ATRIAL FLUTTER | 2 0.02 8.30 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 40 0.40 8.70 B-CELL LYMPHOMA | 20 0.20 8.90 B-CELL LYMPHOMA STAGE IV | 3 0.03 8.93 B-CELL SMALL LYMPHOCYTIC LYMPHOMA | 1 0.01 8.94 BACK PAIN | 45 0.45 9.39 BACTERAEMIA | 3 0.03 9.42 BACTERIAL INFECTION | 2 0.02 9.44 BACTERIAL PYELONEPHRITIS | 1 0.01 9.45 BACTERIAL SEPSIS | 1 0.01 9.46 BALANCE DISORDER | 1 0.01 9.47 BEHCET'S SYNDROME | 2 0.02 9.49 BENIGN PROSTATIC HYPERPLASIA | 19 0.19 9.68 BILE DUCT CANCER | 3 0.03 9.71 BILIARY CANCER METASTATIC | 2 0.02 9.73 BILIARY CIRRHOSIS PRIMARY | 1 0.01 9.74 BIOPSY LYMPH GLAND | 1 0.01 9.75 BIPOLAR DISORDER | 78 0.78 10.53 BIPOLAR I DISORDER | 12 0.12 10.65 BIPOLAR II DISORDER | 1 0.01 10.66 BLADDER CANCER | 12 0.12 10.78 BLADDER DISORDER | 3 0.03 10.81 BLADDER PROLAPSE | 1 0.01 10.82 BLOOD CHOLESTEROL | 23 0.23 11.05 BLOOD CHOLESTEROL ABNORMAL | 2 0.02 11.07 BLOOD CHOLESTEROL INCREASED | 58 0.58 11.65 BLOOD GLUCOSE | 1 0.01 11.66 BLOOD GLUCOSE ABNORMAL | 2 0.02 11.68 BLOOD GLUCOSE INCREASED | 4 0.04 11.72 BLOOD GROWTH HORMONE DECREASED | 1 0.01 11.73 BLOOD IMMUNOGLOBULIN M DECREASED | 1 0.01 11.74 BLOOD IRON | 1 0.01 11.75 BLOOD IRON INCREASED | 1 0.01 11.76 BLOOD PHOSPHORUS INCREASED | 1 0.01 11.77 BLOOD PRESSURE | 37 0.37 12.14 BLOOD PRESSURE INCREASED | 14 0.14 12.28 BLOOD PRESSURE MANAGEMENT | 1 0.01 12.29 BLOOD THYROID STIMULATING HORMONE DEC.. | 1 0.01 12.30 BLOOD THYROID STIMULATING HORMONE INC.. | 1 0.01 12.31 BLOOD TRIGLYCERIDES INCREASED | 2 0.02 12.33 BLOOD URIC ACID | 2 0.02 12.35 BODY HEIGHT BELOW NORMAL | 2 0.02 12.37 BONE DENSITY DECREASED | 1 0.01 12.38 BONE DISORDER | 6 0.06 12.44 BONE MARROW TRANSPLANT | 17 0.17 12.61 BONE PAIN | 2 0.02 12.63 BONE SARCOMA | 4 0.04 12.67 BORDERLINE PERSONALITY DISORDER | 5 0.05 12.72 BRAIN DAMAGE | 1 0.01 12.73 BRAIN NEOPLASM MALIGNANT | 2 0.02 12.75 BRAIN OEDEMA | 2 0.02 12.77 BREAKTHROUGH PAIN | 4 0.04 12.81 BREAST CANCER | 401 4.01 16.82 BREAST CANCER FEMALE | 98 0.98 17.80 BREAST CANCER IN SITU | 5 0.05 17.85 BREAST CANCER MALE | 1 0.01 17.86 BREAST CANCER METASTATIC | 89 0.89 18.75 BREAST CANCER RECURRENT | 9 0.09 18.84 BREAST CANCER STAGE I | 6 0.06 18.90 BREAST CANCER STAGE II | 2 0.02 18.92 BREAST CANCER STAGE III | 5 0.05 18.97 BREAST CANCER STAGE IV | 3 0.03 19.00 BRONCHIAL CARCINOMA | 2 0.02 19.02 BRONCHIECTASIS | 3 0.03 19.05 BRONCHITIS | 51 0.51 19.56 BRONCHITIS CHRONIC | 3 0.03 19.59 BRONCHOPNEUMONIA | 5 0.05 19.64 BRONCHOPNEUMOPATHY | 1 0.01 19.65 BRONCHOPULMONARY ASPERGILLOSIS | 3 0.03 19.68 BUDD-CHIARI SYNDROME | 1 0.01 19.69 BULIMIA NERVOSA | 1 0.01 19.70 BURKHOLDERIA CEPACIA INFECTION | 1 0.01 19.71 BURKITT'S LYMPHOMA | 17 0.17 19.88 BURKITT'S LYMPHOMA STAGE III | 6 0.06 19.94 BURNING SENSATION | 1 0.01 19.95 BURSITIS | 1 0.01 19.96 CANCER PAIN | 23 0.23 20.19 CARCINOID TUMOUR | 5 0.05 20.24 CARCINOMA IN SITU OF BLADDER | 2 0.02 20.26 CARDIAC DISORDER | 26 0.26 20.52 CARDIAC FAILURE | 17 0.17 20.69 CARDIAC FAILURE CHRONIC | 5 0.05 20.74 CARDIAC FAILURE CONGESTIVE | 13 0.13 20.87 CARDIAC FIBRILLATION | 2 0.02 20.89 CARDIAC OPERATION | 1 0.01 20.90 CARDIOMYOPATHY | 1 0.01 20.91 CARDIOVASCULAR DISORDER | 13 0.13 21.04 CARDIOVASCULAR EVENT PROPHYLAXIS | 4 0.04 21.08 CAROTID ARTERY STENOSIS | 1 0.01 21.09 CATARACT | 3 0.03 21.12 CATARACT OPERATION COMPLICATION | 1 0.01 21.13 CATHETER RELATED COMPLICATION | 1 0.01 21.14 CATHETER RELATED INFECTION | 3 0.03 21.17 CATHETERISATION CARDIAC | 1 0.01 21.18 CELLULITIS | 1 0.01 21.19 CEREBRAL ARTERY EMBOLISM | 2 0.02 21.21 CEREBRAL DISORDER | 1 0.01 21.22 CEREBRAL HAEMORRHAGE | 1 0.01 21.23 CEREBRAL INFARCTION | 7 0.07 21.30 CEREBROVASCULAR ACCIDENT | 7 0.07 21.37 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 2 0.02 21.39 CERVIX CANCER METASTATIC | 2 0.02 21.41 CHEMOTHERAPEUTIC DRUG LEVEL ABOVE THE.. | 2 0.02 21.43 CHEMOTHERAPY | 12 0.12 21.55 CHEST PAIN | 2 0.02 21.57 CHEST X-RAY ABNORMAL | 1 0.01 21.58 CHLAMYDIAL INFECTION | 2 0.02 21.60 CHOLANGIOGRAM | 1 0.01 21.61 CHOLANGITIS | 1 0.01 21.62 CHOLELITHIASIS | 2 0.02 21.64 CHOROIDAL NEOVASCULARISATION | 3 0.03 21.67 CHRONIC HEPATITIS | 1 0.01 21.68 CHRONIC LYMPHOCYTIC LEUKAEMIA | 19 0.19 21.87 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 4 | 2 0.02 21.89 CHRONIC MYELOID LEUKAEMIA | 31 0.31 22.20 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 47 0.47 22.67 CHRONIC SINUSITIS | 1 0.01 22.68 CIRCADIAN RHYTHM SLEEP DISORDER | 1 0.01 22.69 CIRCUMCISION | 4 0.04 22.73 CIRRHOSIS ALCOHOLIC | 1 0.01 22.74 CLOSTRIDIAL INFECTION | 1 0.01 22.75 CLOSTRIDIUM DIFFICILE COLITIS | 1 0.01 22.76 COAGULOPATHY | 4 0.04 22.80 COGNITIVE DISORDER | 4 0.04 22.84 COLITIS | 2 0.02 22.86 COLITIS ULCERATIVE | 13 0.13 22.99 COLON CANCER | 38 0.38 23.37 COLON CANCER METASTATIC | 5 0.05 23.42 COLON CANCER STAGE III | 4 0.04 23.46 COLONOSCOPY | 8 0.08 23.54 COLORECTAL CANCER | 32 0.32 23.86 COLORECTAL CANCER METASTATIC | 38 0.38 24.24 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 24.25 COMPUTERISED TOMOGRAM | 4 0.04 24.29 COMPUTERISED TOMOGRAM THORAX | 1 0.01 24.30 CONGENITAL CYSTIC KIDNEY DISEASE | 2 0.02 24.32 CONGENITAL TERATOMA | 1 0.01 24.33 CONGESTIVE CARDIOMYOPATHY | 1 0.01 24.34 CONSTIPATION | 38 0.38 24.72 CONSTIPATION PROPHYLAXIS | 1 0.01 24.73 CONTRACEPTION | 49 0.49 25.22 CONVULSION | 31 0.31 25.53 CONVULSION PROPHYLAXIS | 7 0.07 25.60 CORD BLOOD TRANSPLANT THERAPY | 4 0.04 25.64 CORONARY ARTERY BYPASS | 3 0.03 25.67 CORONARY ARTERY DISEASE | 11 0.11 25.78 COUGH | 13 0.13 25.91 CROHN'S DISEASE | 45 0.45 26.36 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 26.37 CYSTITIS | 3 0.03 26.40 CYSTOPEXY | 1 0.01 26.41 CYSTOSCOPY | 1 0.01 26.42 CYTOMEGALOVIRUS INFECTION | 1 0.01 26.43 DEEP VEIN THROMBOSIS | 5 0.05 26.48 DEFAECATION URGENCY | 1 0.01 26.49 DELUSION | 2 0.02 26.51 DELUSIONAL DISORDER, PERSECUTORY TYPE | 3 0.03 26.54 DEMENTIA | 3 0.03 26.57 DEMENTIA ALZHEIMER'S TYPE | 17 0.17 26.74 DENTAL DISORDER PROPHYLAXIS | 1 0.01 26.75 DENTAL IMPLANTATION | 1 0.01 26.76 DENTAL OPERATION | 1 0.01 26.77 DENTAL TREATMENT | 1 0.01 26.78 DEPRESSED MOOD | 4 0.04 26.82 DEPRESSION | 233 2.33 29.15 DEPRESSIVE SYMPTOM | 2 0.02 29.17 DERMATITIS CONTACT | 1 0.01 29.18 DERMATOMYOSITIS | 6 0.06 29.24 DETACHMENT OF RETINAL PIGMENT EPITHEL.. | 5 0.05 29.29 DEVICE RELATED INFECTION | 2 0.02 29.31 DIABETES INSIPIDUS | 1 0.01 29.32 DIABETES MELLITUS | 122 1.22 30.54 DIABETES MELLITUS INADEQUATE CONTROL | 2 0.02 30.56 DIABETIC FOOT INFECTION | 1 0.01 30.57 DIABETIC NEPHROPATHY | 2 0.02 30.59 DIABETIC NEUROPATHY | 3 0.03 30.62 DIABETIC RETINAL OEDEMA | 3 0.03 30.65 DIALYSIS | 8 0.08 30.73 DIARRHOEA | 20 0.20 30.93 DIFFUSE LARGE B-CELL LYMPHOMA | 11 0.11 31.04 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV | 9 0.09 31.13 DISCOMFORT | 1 0.01 31.14 DISSEMINATED INTRAVASCULAR COAGULATION | 1 0.01 31.15 DIURETIC THERAPY | 3 0.03 31.18 DIVERTICULITIS | 3 0.03 31.21 DIZZINESS | 3 0.03 31.24 DRUG ABUSER | 5 0.05 31.29 DRUG DEPENDENCE | 2 0.02 31.31 DRUG EXPOSURE DURING PREGNANCY | 46 0.46 31.77 DRUG LEVEL ABOVE THERAPEUTIC | 1 0.01 31.78 DRUG THERAPY | 1 0.01 31.79 DRUG USE FOR UNKNOWN INDICATION | 1,282 12.82 44.61 DRUG WITHDRAWAL SYNDROME | 3 0.03 44.64 DRUG WITHDRAWAL SYNDROME NEONATAL | 1 0.01 44.65 DRY EYE | 2 0.02 44.67 DRY MOUTH | 1 0.01 44.68 DRY SKIN | 4 0.04 44.72 DUODENAL ULCER | 3 0.03 44.75 DYSLIPIDAEMIA | 8 0.08 44.83 DYSPEPSIA | 25 0.25 45.08 DYSPHONIA | 1 0.01 45.09 DYSPNOEA | 4 0.04 45.13 DYSTHYMIC DISORDER | 1 0.01 45.14 DYSTONIA | 1 0.01 45.15 DYSURIA | 2 0.02 45.17 EAR DISORDER | 1 0.01 45.18 EAR INFECTION | 1 0.01 45.19 ECZEMA | 6 0.06 45.25 ELECTROLYTE SUBSTITUTION THERAPY | 1 0.01 45.26 EMPHYSEMA | 12 0.12 45.38 ENCEPHALOPATHY | 3 0.03 45.41 ENDOMETRIOSIS | 3 0.03 45.44 ENDOSCOPIC RETROGRADE CHOLANGIOPANCRE.. | 1 0.01 45.45 ENDOSCOPY LARGE BOWEL | 1 0.01 45.46 ENTEROCOCCAL INFECTION | 1 0.01 45.47 ENTEROCUTANEOUS FISTULA | 1 0.01 45.48 ENURESIS | 2 0.02 45.50 EPHELIDES | 1 0.01 45.51 EPIDURAL TEST DOSE | 2 0.02 45.53 EPILEPSY | 65 0.65 46.18 ERECTILE DYSFUNCTION | 16 0.16 46.34 ERYSIPELAS | 4 0.04 46.38 ERYTHRODERMIC PSORIASIS | 1 0.01 46.39 ESSENTIAL HYPERTENSION | 4 0.04 46.43 ESSENTIAL THROMBOCYTHAEMIA | 1 0.01 46.44 ESSENTIAL TREMOR | 3 0.03 46.47 EUSTACHIAN TUBE DYSFUNCTION | 1 0.01 46.48 EVIDENCE BASED TREATMENT | 1 0.01 46.49 EX-SMOKER | 23 0.23 46.72 EXCHANGE BLOOD TRANSFUSION | 1 0.01 46.73 EXTRACORPOREAL CIRCULATION | 1 0.01 46.74 EXTRADURAL ABSCESS | 6 0.06 46.80 EXTRAPYRAMIDAL DISORDER | 2 0.02 46.82 EYE DISORDER | 1 0.01 46.83 EYE IRRITATION | 1 0.01 46.84 EYE PRURITUS | 1 0.01 46.85 FABRY'S DISEASE | 6 0.06 46.91 FACIAL NEURALGIA | 1 0.01 46.92 FACIAL PALSY | 1 0.01 46.93 FACIAL SPASM | 1 0.01 46.94 FALL | 1 0.01 46.95 FALLOPIAN TUBE CANCER | 4 0.04 46.99 FALLOT'S TETRALOGY | 3 0.03 47.02 FAMILIAL MEDITERRANEAN FEVER | 4 0.04 47.06 FAT INTOLERANCE | 1 0.01 47.07 FATIGUE | 3 0.03 47.10 FEBRILE NEUTROPENIA | 2 0.02 47.12 FEELING OF RELAXATION | 1 0.01 47.13 FEMORAL NECK FRACTURE | 1 0.01 47.14 FIBROMYALGIA | 11 0.11 47.25 FISTULA | 1 0.01 47.26 FLATULENCE | 1 0.01 47.27 FLUID OVERLOAD | 1 0.01 47.28 FLUID REPLACEMENT | 1 0.01 47.29 FLUID RETENTION | 2 0.02 47.31 FOLATE DEFICIENCY | 1 0.01 47.32 FOLLICULITIS | 3 0.03 47.35 FOOD ALLERGY | 1 0.01 47.36 FRACTURE | 1 0.01 47.37 FUNGAL INFECTION | 9 0.09 47.46 GALLBLADDER CANCER | 1 0.01 47.47 GASTRIC BYPASS | 2 0.02 47.49 GASTRIC CANCER | 10 0.10 47.59 GASTRIC DISORDER | 4 0.04 47.63 GASTRIC MUCOSAL LESION | 1 0.01 47.64 GASTRIC ULCER | 15 0.15 47.79 GASTRITIS | 23 0.23 48.02 GASTRITIS PROPHYLAXIS | 1 0.01 48.03 GASTRODUODENAL ULCER | 1 0.01 48.04 GASTROENTERITIS | 1 0.01 48.05 GASTROINTESTINAL DISORDER | 5 0.05 48.10 GASTROINTESTINAL INFLAMMATION | 3 0.03 48.13 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 48.14 GASTROINTESTINAL MUCOSAL DISORDER | 1 0.01 48.15 GASTROINTESTINAL PAIN | 2 0.02 48.17 GASTROINTESTINAL STROMAL TUMOUR | 12 0.12 48.29 GASTROOESOPHAGEAL REFLUX DISEASE | 29 0.29 48.58 GASTROOESOPHAGEAL REFLUX PROPHYLAXIS | 2 0.02 48.60 GAUCHER'S DISEASE | 7 0.07 48.67 GENERAL ANAESTHESIA | 23 0.23 48.90 GENERAL PHYSICAL HEALTH DETERIORATION | 2 0.02 48.92 GENERALISED ANXIETY DISORDER | 2 0.02 48.94 GENITAL HERPES | 5 0.05 48.99 GERM CELL CANCER | 48 0.48 49.47 GIGANTISM | 1 0.01 49.48 GLAUCOMA | 8 0.08 49.56 GLIOBLASTOMA | 2 0.02 49.58 GLIOBLASTOMA MULTIFORME | 14 0.14 49.72 GLIOMA | 1 0.01 49.73 GLOMERULOSCLEROSIS | 4 0.04 49.77 GLUCOSE TOLERANCE IMPAIRED | 4 0.04 49.81 GLYCOGEN STORAGE DISEASE TYPE II | 4 0.04 49.85 GOUT | 6 0.06 49.91 GRAFT VERSUS HOST DISEASE | 2 0.02 49.93 GRAND MAL CONVULSION | 5 0.05 49.98 GROWTH HORMONE DEFICIENCY | 10 0.10 50.08 GROWTH RETARDATION | 1 0.01 50.09 GUILLAIN-BARRE SYNDROME | 2 0.02 50.11 HAEMODIALYSIS | 1 0.01 50.12 HAEMOGLOBIN | 1 0.01 50.13 HAEMORRHAGE | 6 0.06 50.19 HAEMORRHOIDS | 6 0.06 50.25 HAEMOSIDEROSIS | 1 0.01 50.26 HALLUCINATION | 2 0.02 50.28 HEADACHE | 16 0.16 50.44 HEART TRANSPLANT | 7 0.07 50.51 HELICOBACTER INFECTION | 8 0.08 50.59 HEPATIC CIRRHOSIS | 5 0.05 50.64 HEPATIC MASS | 2 0.02 50.66 HEPATIC NEOPLASM MALIGNANT | 6 0.06 50.72 HEPATITIS | 2 0.02 50.74 HEPATITIS B | 8 0.08 50.82 HEPATITIS C | 80 0.80 51.62 HERPES SIMPLEX | 1 0.01 51.63 HERPES VIRUS INFECTION | 2 0.02 51.65 HERPES ZOSTER | 17 0.17 51.82 HIATUS HERNIA | 7 0.07 51.89 HICCUPS | 1 0.01 51.90 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 51.91 HIGH GRADE B-CELL LYMPHOMA BURKITT-LI.. | 4 0.04 51.95 HISTOPLASMOSIS | 1 0.01 51.96 HIV INFECTION | 160 1.60 53.56 HODGKIN'S DISEASE | 3 0.03 53.59 HORDEOLUM | 1 0.01 53.60 HORMONE REPLACEMENT THERAPY | 42 0.42 54.02 HORMONE SUPPRESSION THERAPY | 1 0.01 54.03 HOT FLUSH | 4 0.04 54.07 HUMAN IMMUNODEFICIENCY VIRUS TRANSMIS.. | 3 0.03 54.10 HYPERCALCAEMIA OF MALIGNANCY | 3 0.03 54.13 HYPERCHOLESTEROLAEMIA | 34 0.34 54.47 HYPERCOAGULATION | 1 0.01 54.48 HYPERGLYCAEMIA | 4 0.04 54.52 HYPERINSULINISM | 1 0.01 54.53 HYPERKALAEMIA | 1 0.01 54.54 HYPERKERATOSIS PALMARIS AND PLANTARIS | 2 0.02 54.56 HYPERLIPIDAEMIA | 37 0.37 54.93 HYPERPARATHYROIDISM | 1 0.01 54.94 HYPERPARATHYROIDISM SECONDARY | 16 0.16 55.10 HYPERPHOSPHATAEMIA | 3 0.03 55.13 HYPERSENSITIVITY | 22 0.22 55.35 HYPERTENSION | 478 4.78 60.13 HYPERTENSIVE HEART DISEASE | 5 0.05 60.18 HYPERTHYROIDISM | 1 0.01 60.19 HYPERTONIA | 1 0.01 60.20 HYPERTONIC BLADDER | 3 0.03 60.23 HYPERTRIGLYCERIDAEMIA | 1 0.01 60.24 HYPERURICAEMIA | 9 0.09 60.33 HYPOAESTHESIA | 3 0.03 60.36 HYPOGAMMAGLOBULINAEMIA | 1 0.01 60.37 HYPOGLYCAEMIA | 1 0.01 60.38 HYPOGONADISM | 3 0.03 60.41 HYPONATRAEMIA | 1 0.01 60.42 HYPOPARATHYROIDISM SECONDARY | 1 0.01 60.43 HYPOPITUITARISM | 8 0.08 60.51 HYPOTHYROIDISM | 31 0.31 60.82 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 60.83 ILL-DEFINED DISORDER | 108 1.08 61.91 IMMUNODEFICIENCY | 1 0.01 61.92 IMMUNODEFICIENCY COMMON VARIABLE | 1 0.01 61.93 IMMUNOSUPPRESSANT DRUG THERAPY | 3 0.03 61.96 IMMUNOSUPPRESSION | 14 0.14 62.10 IMPAIRED GASTRIC EMPTYING | 2 0.02 62.12 INCONTINENCE | 4 0.04 62.16 INDUCTION OF ANAESTHESIA | 10 0.10 62.26 INFARCTION | 4 0.04 62.30 INFECTION | 21 0.21 62.51 INFECTION PROPHYLAXIS | 13 0.13 62.64 INFILTRATION ANAESTHESIA | 2 0.02 62.66 INFLAMMATION | 8 0.08 62.74 INFLAMMATORY BOWEL DISEASE | 2 0.02 62.76 INITIAL INSOMNIA | 2 0.02 62.78 INJURY | 1 0.01 62.79 INSOMNIA | 111 1.11 63.90 INSULIN-REQUIRING TYPE II DIABETES ME.. | 2 0.02 63.92 INTENTIONAL DRUG MISUSE | 3 0.03 63.95 INTENTIONAL OVERDOSE | 8 0.08 64.03 INTERNATIONAL NORMALISED RATIO | 1 0.01 64.04 INTERSTITIAL LUNG DISEASE | 2 0.02 64.06 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 64.07 INTERVERTEBRAL DISC PROTRUSION | 3 0.03 64.10 INTESTINAL OPERATION | 1 0.01 64.11 INTRA-UTERINE DEATH | 1 0.01 64.12 INTRAOCULAR PRESSURE INCREASED | 1 0.01 64.13 INTRAOCULAR PRESSURE TEST | 2 0.02 64.15 IRON DEFICIENCY | 2 0.02 64.17 IRON DEFICIENCY ANAEMIA | 4 0.04 64.21 IRON OVERLOAD | 8 0.08 64.29 IRRITABILITY | 1 0.01 64.30 IRRITABLE BOWEL SYNDROME | 7 0.07 64.37 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 6 0.06 64.43 ISCHAEMIC STROKE | 2 0.02 64.45 JOINT DISLOCATION | 1 0.01 64.46 JOINT INJURY | 3 0.03 64.49 JOINT SPRAIN | 1 0.01 64.50 JOINT SWELLING | 1 0.01 64.51 JUVENILE ARTHRITIS | 9 0.09 64.60 KIDNEY INFECTION | 1 0.01 64.61 KIDNEY TRANSPLANT REJECTION | 4 0.04 64.65 LARYNGEAL CANCER | 4 0.04 64.69 LAXATIVE SUPPORTIVE CARE | 2 0.02 64.71 LEARNING DISABILITY | 3 0.03 64.74 LEGIONELLA INFECTION | 1 0.01 64.75 LEIOMYOSARCOMA | 1 0.01 64.76 LEUKAEMIA | 1 0.01 64.77 LEUKAEMIA BASOPHILIC | 1 0.01 64.78 LICE INFESTATION | 3 0.03 64.81 LIP AND/OR ORAL CAVITY CANCER | 2 0.02 64.83 LIP DISORDER | 1 0.01 64.84 LIPIDS INCREASED | 2 0.02 64.86 LIVER ABSCESS | 1 0.01 64.87 LIVER TRANSPLANT | 10 0.10 64.97 LOCAL ANAESTHESIA | 2 0.02 64.99 LOCAL ANTIFUNGAL TREATMENT | 1 0.01 65.00 LOCALISED INFECTION | 1 0.01 65.01 LOW DENSITY LIPOPROTEIN | 1 0.01 65.02 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 65.03 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 65.05 LUMBAR HERNIA | 6 0.06 65.11 LUMBAR RADICULOPATHY | 1 0.01 65.12 LUMBAR SPINAL STENOSIS | 1 0.01 65.13 LUNG ADENOCARCINOMA | 1 0.01 65.14 LUNG ADENOCARCINOMA METASTATIC | 2 0.02 65.16 LUNG ADENOCARCINOMA RECURRENT | 2 0.02 65.18 LUNG CANCER METASTATIC | 3 0.03 65.21 LUNG DISORDER | 9 0.09 65.30 LUNG INFECTION | 1 0.01 65.31 LUNG NEOPLASM MALIGNANT | 10 0.10 65.41 LUNG TRANSPLANT | 2 0.02 65.43 LYMPHADENECTOMY | 1 0.01 65.44 LYMPHOMA | 6 0.06 65.50 MACULAR DEGENERATION | 32 0.32 65.82 MAINTENANCE OF ANAESTHESIA | 8 0.08 65.90 MAJOR DEPRESSION | 14 0.14 66.04 MALARIA PROPHYLAXIS | 10 0.10 66.14 MALE PATTERN BALDNESS | 5 0.05 66.19 MALIGNANT BREAST LUMP REMOVAL | 2 0.02 66.21 MALIGNANT GLIOMA | 2 0.02 66.23 MALIGNANT MELANOMA | 9 0.09 66.32 MANIA | 5 0.05 66.37 MANTLE CELL LYMPHOMA | 14 0.14 66.51 MASTECTOMY | 3 0.03 66.54 MATERNAL THERAPY TO ENHANCE FOETAL LU.. | 1 0.01 66.55 MECHANICAL VENTILATION | 1 0.01 66.56 MEDICAL DIET | 8 0.08 66.64 MELAENA | 4 0.04 66.68 MENIERE'S DISEASE | 1 0.01 66.69 MENINGITIS | 1 0.01 66.70 MENINGITIS BACTERIAL | 2 0.02 66.72 MENINGITIS CRYPTOCOCCAL | 1 0.01 66.73 MENOPAUSAL SYMPTOMS | 34 0.34 67.07 MENOPAUSE | 5 0.05 67.12 MENORRHAGIA | 1 0.01 67.13 MENSTRUAL DISORDER | 1 0.01 67.14 MENSTRUATION IRREGULAR | 5 0.05 67.19 MENTAL DISORDER | 1 0.01 67.20 METASTASES TO BLADDER | 2 0.02 67.22 METASTASES TO BONE | 38 0.38 67.60 METASTASES TO LUNG | 1 0.01 67.61 METASTASES TO LYMPH NODES | 1 0.01 67.62 METASTASIS | 1 0.01 67.63 METASTATIC GASTRIC CANCER | 1 0.01 67.64 METASTATIC MALIGNANT MELANOMA | 1 0.01 67.65 METASTATIC RENAL CELL CARCINOMA | 21 0.21 67.86 MICTURITION DISORDER | 1 0.01 67.87 MICTURITION URGENCY | 2 0.02 67.89 MIGRAINE | 16 0.16 68.05 MIGRAINE PROPHYLAXIS | 6 0.06 68.11 MINERAL SUPPLEMENTATION | 5 0.05 68.16 MITRAL VALVE REPLACEMENT | 1 0.01 68.17 MIXED HEPATOCELLULAR CHOLANGIOCARCINOMA | 1 0.01 68.18 MODERATE MENTAL RETARDATION | 1 0.01 68.19 MODIFIED RADICAL MASTECTOMY | 1 0.01 68.20 MOOD ALTERED | 2 0.02 68.22 MOOD SWINGS | 3 0.03 68.25 MUCOSAL INFLAMMATION | 2 0.02 68.27 MULTIPLE ALLERGIES | 11 0.11 68.38 MULTIPLE FRACTURES | 1 0.01 68.39 MULTIPLE INJURIES | 1 0.01 68.40 MULTIPLE MYELOMA | 83 0.83 69.23 MULTIPLE SCLEROSIS | 156 1.56 70.79 MUSCLE RELAXANT THERAPY | 9 0.09 70.88 MUSCLE RIGIDITY | 1 0.01 70.89 MUSCLE SPASMS | 15 0.15 71.04 MUSCLE SPASTICITY | 11 0.11 71.15 MUSCULOSKELETAL CHEST PAIN | 3 0.03 71.18 MUSCULOSKELETAL PAIN | 11 0.11 71.29 MUSCULOSKELETAL STIFFNESS | 1 0.01 71.30 MYALGIA | 10 0.10 71.40 MYASTHENIA GRAVIS | 5 0.05 71.45 MYCOBACTERIAL INFECTION | 3 0.03 71.48 MYCOBACTERIUM KANSASII INFECTION | 1 0.01 71.49 MYCOSIS FUNGOIDES | 2 0.02 71.51 MYELODYSPLASTIC SYNDROME | 12 0.12 71.63 MYOCARDIAL INFARCTION | 11 0.11 71.74 MYOCARDIAL ISCHAEMIA | 12 0.12 71.86 MYOFASCIAL PAIN SYNDROME | 1 0.01 71.87 NAIL TINEA | 7 0.07 71.94 NARCOLEPSY | 4 0.04 71.98 NASAL CONGESTION | 1 0.01 71.99 NASOPHARYNGITIS | 12 0.12 72.11 NAUSEA | 13 0.13 72.24 NECK PAIN | 5 0.05 72.29 NEOPLASM | 3 0.03 72.32 NEOPLASM MALIGNANT | 9 0.09 72.41 NEOPLASM PROPHYLAXIS | 1 0.01 72.42 NEPHRITIS | 2 0.02 72.44 NEPHROGENIC ANAEMIA | 1 0.01 72.45 NEPHROLITHIASIS | 2 0.02 72.47 NEPHROTIC SYNDROME | 3 0.03 72.50 NERVE BLOCK | 3 0.03 72.53 NERVOUS SYSTEM DISORDER | 2 0.02 72.55 NERVOUSNESS | 2 0.02 72.57 NEURALGIA | 23 0.23 72.80 NEUROBLASTOMA | 3 0.03 72.83 NEUROGENIC BLADDER | 1 0.01 72.84 NEUROLOGICAL SYMPTOM | 1 0.01 72.85 NEUROPATHY | 4 0.04 72.89 NEUROPATHY PERIPHERAL | 14 0.14 73.03 NEUTROPENIA | 2 0.02 73.05 NOCTURIA | 3 0.03 73.08 NON-CARDIAC CHEST PAIN | 1 0.01 73.09 NON-HODGKIN'S LYMPHOMA | 43 0.43 73.52 NON-SMALL CELL LUNG CANCER | 37 0.37 73.89 NON-SMALL CELL LUNG CANCER METASTATIC | 3 0.03 73.92 NUCLEAR MAGNETIC RESONANCE IMAGING | 3 0.03 73.95 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 2 0.02 73.97 NUTRITIONAL SUPPORT | 2 0.02 73.99 OBESITY | 11 0.11 74.10 OBSESSIVE-COMPULSIVE DISORDER | 8 0.08 74.18 OEDEMA | 17 0.17 74.35 OEDEMA PERIPHERAL | 2 0.02 74.37 OESOPHAGEAL CANDIDIASIS | 1 0.01 74.38 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 4 0.04 74.42 OESOPHAGITIS | 3 0.03 74.45 OESTRADIOL DECREASED | 1 0.01 74.46 OESTROGEN REPLACEMENT THERAPY | 10 0.10 74.56 OFF LABEL USE | 2 0.02 74.58 ONYCHOMYCOSIS | 2 0.02 74.60 OPPORTUNISTIC INFECTION PROPHYLAXIS | 4 0.04 74.64 ORAL CANDIDIASIS | 2 0.02 74.66 ORAL CONTRACEPTION | 11 0.11 74.77 ORAL FUNGAL INFECTION | 2 0.02 74.79 ORAL HERPES | 1 0.01 74.80 ORAL INFECTION | 1 0.01 74.81 ORGAN TRANSPLANT | 1 0.01 74.82 OROPHARYNGEAL CANDIDIASIS | 1 0.01 74.83 ORTHOPEDIC PROCEDURE | 1 0.01 74.84 OSTEITIS | 2 0.02 74.86 OSTEITIS DEFORMANS | 1 0.01 74.87 OSTEOARTHRITIS | 24 0.24 75.11 OSTEOGENESIS IMPERFECTA | 1 0.01 75.12 OSTEOMYELITIS | 2 0.02 75.14 OSTEOPENIA | 7 0.07 75.21 OSTEOPOROSIS | 147 1.47 76.68 OSTEOPOROSIS POSTMENOPAUSAL | 2 0.02 76.70 OSTEOPOROSIS PROPHYLAXIS | 2 0.02 76.72 OSTEOSARCOMA LOCALISED | 4 0.04 76.76 OSTEOTOMY | 3 0.03 76.79 OTITIS EXTERNA | 1 0.01 76.80 OTITIS MEDIA | 1 0.01 76.81 OVARIAN CANCER | 15 0.15 76.96 OVULATION INDUCTION | 3 0.03 76.99 PAIN | 206 2.06 79.05 PAIN IN EXTREMITY | 14 0.14 79.19 PAIN IN JAW | 1 0.01 79.20 PAIN MANAGEMENT | 13 0.13 79.33 PALLIATIVE CARE | 1 0.01 79.34 PALPITATIONS | 1 0.01 79.35 PANCREATIC CARCINOMA | 13 0.13 79.48 PANCREATIC CARCINOMA METASTATIC | 6 0.06 79.54 PANCREATIC CARCINOMA STAGE IV | 2 0.02 79.56 PANCREATITIS | 2 0.02 79.58 PANIC ATTACK | 4 0.04 79.62 PANIC DISORDER | 8 0.08 79.70 PAPILLOMA VIRAL INFECTION | 1 0.01 79.71 PARAESTHESIA | 1 0.01 79.72 PARANOIA | 3 0.03 79.75 PARENTERAL NUTRITION | 2 0.02 79.77 PARKINSON'S DISEASE | 79 0.79 80.56 PARTIAL SEIZURES | 2 0.02 80.58 PATENT DUCTUS ARTERIOSUS | 1 0.01 80.59 PEMPHIGUS | 2 0.02 80.61 PEPTIC ULCER | 2 0.02 80.63 PERCUTANEOUS CORONARY INTERVENTION | 3 0.03 80.66 PERIARTHRITIS | 2 0.02 80.68 PERICARDITIS | 2 0.02 80.70 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 4 0.04 80.74 PERIPHERAL BLOOD STEM CELL APHERESIS | 1 0.01 80.75 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 80.76 PERIPHERAL VASCULAR DISORDER | 2 0.02 80.78 PERITONEAL CARCINOMA | 3 0.03 80.81 PERITONEAL DIALYSIS | 21 0.21 81.02 PERITONITIS | 1 0.01 81.03 PERNICIOUS ANAEMIA | 2 0.02 81.05 PERSONALITY DISORDER | 5 0.05 81.10 PEYRONIE'S DISEASE | 4 0.04 81.14 PHARYNGEAL ULCERATION | 1 0.01 81.15 PHARYNGOLARYNGEAL PAIN | 2 0.02 81.17 PHARYNGOTONSILLITIS | 3 0.03 81.20 PHLEBITIS | 1 0.01 81.21 PHOTODYNAMIC THERAPY | 1 0.01 81.22 PIGMENTARY GLAUCOMA | 2 0.02 81.24 PITUITARY TUMOUR BENIGN | 1 0.01 81.25 PLANTAR FASCIITIS | 1 0.01 81.26 PLASMACYTOMA | 1 0.01 81.27 PLATELET AGGREGATION | 1 0.01 81.28 PLEURAL EFFUSION | 3 0.03 81.31 PLEURAL MESOTHELIOMA | 2 0.02 81.33 PLEURAL MESOTHELIOMA MALIGNANT | 13 0.13 81.46 PLEURITIC PAIN | 1 0.01 81.47 PNEUMOCONIOSIS | 1 0.01 81.48 PNEUMOCYSTIS JIROVECI INFECTION | 1 0.01 81.49 PNEUMOCYSTIS JIROVECI PNEUMONIA | 2 0.02 81.51 PNEUMONIA | 35 0.35 81.86 PNEUMONIA BACTERIAL | 9 0.09 81.95 PNEUMONIA CRYPTOCOCCAL | 1 0.01 81.96 PNEUMONIA LEGIONELLA | 3 0.03 81.99 PNEUMONIA PRIMARY ATYPICAL | 2 0.02 82.01 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 82.02 PNEUMONIA STREPTOCOCCAL | 1 0.01 82.03 POLLAKIURIA | 7 0.07 82.10 POLYARTERITIS NODOSA | 2 0.02 82.12 POLYCYSTIC OVARIES | 1 0.01 82.13 POLYCYTHAEMIA VERA | 1 0.01 82.14 POLYMYOSITIS | 1 0.01 82.15 POLYNEUROPATHY | 5 0.05 82.20 POLYURIA | 10 0.10 82.30 POOR QUALITY SLEEP | 1 0.01 82.31 POST HERPETIC NEURALGIA | 3 0.03 82.34 POST PROCEDURAL HAEMORRHAGE | 1 0.01 82.35 POST-TRAUMATIC STRESS DISORDER | 1 0.01 82.36 POSTNASAL DRIP | 1 0.01 82.37 POSTOPERATIVE ANALGESIA | 4 0.04 82.41 POSTOPERATIVE CARE | 2 0.02 82.43 POSTOPERATIVE FEVER | 1 0.01 82.44 POSTPARTUM DEPRESSION | 1 0.01 82.45 POSTPARTUM DISORDER | 1 0.01 82.46 PRADER-WILLI SYNDROME | 2 0.02 82.48 PRE-ECLAMPSIA | 6 0.06 82.54 PRE-EXISTING DISEASE | 1 0.01 82.55 PREGNANCY | 2 0.02 82.57 PREMATURE LABOUR | 1 0.01 82.58 PREMEDICATION | 32 0.32 82.90 PREMENSTRUAL SYNDROME | 2 0.02 82.92 PREOPERATIVE CARE | 19 0.19 83.11 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 83.12 PRINZMETAL ANGINA | 3 0.03 83.15 PROCEDURAL PAIN | 5 0.05 83.20 PROCTALGIA | 1 0.01 83.21 PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 83.22 PROLACTINOMA | 1 0.01 83.23 PROPHYLACTIC CHEMOTHERAPY | 1 0.01 83.24 PROPHYLAXIS | 107 1.07 84.31 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 12 0.12 84.43 PROPHYLAXIS AGAINST HIV INFECTION | 3 0.03 84.46 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 14 0.14 84.60 PROPHYLAXIS OF NAUSEA AND VOMITING | 7 0.07 84.67 PROSTATE CANCER | 30 0.30 84.97 PROSTATE CANCER METASTATIC | 4 0.04 85.01 PROSTATE EXAMINATION ABNORMAL | 1 0.01 85.02 PROSTATIC DISORDER | 3 0.03 85.05 PROSTATISM | 1 0.01 85.06 PRURITUS | 5 0.05 85.11 PSEUDOMONAS INFECTION | 10 0.10 85.21 PSORIASIS | 53 0.53 85.74 PSORIATIC ARTHROPATHY | 27 0.27 86.01 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 86.02 PSYCHOTIC DISORDER | 36 0.36 86.38 PULMONARY ARTERY THROMBOSIS | 1 0.01 86.39 PULMONARY EMBOLISM | 2 0.02 86.41 PULMONARY FIBROSIS | 4 0.04 86.45 PULMONARY HYPERTENSION | 14 0.14 86.59 PULMONARY THROMBOSIS | 1 0.01 86.60 PULMONARY TUBERCULOSIS | 5 0.05 86.65 PUSTULAR PSORIASIS | 1 0.01 86.66 PYODERMA GANGRENOSUM | 3 0.03 86.69 PYREXIA | 12 0.12 86.81 RADICAL MASTECTOMY | 1 0.01 86.82 RADIOTHERAPY | 1 0.01 86.83 RAPID EYE MOVEMENTS SLEEP ABNORMAL | 1 0.01 86.84 RASH | 4 0.04 86.88 RASH PAPULAR | 1 0.01 86.89 RAYNAUD'S PHENOMENON | 2 0.02 86.91 RECTAL CANCER | 9 0.09 87.00 REFLUX OESOPHAGITIS | 5 0.05 87.05 REITER'S SYNDROME | 1 0.01 87.06 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 16 0.16 87.22 RENAL ARTERY STENOSIS | 1 0.01 87.23 RENAL CANCER METASTATIC | 2 0.02 87.25 RENAL CELL CARCINOMA STAGE IV | 2 0.02 87.27 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 35 0.35 87.62 RENAL COLIC | 3 0.03 87.65 RENAL DISORDER | 2 0.02 87.67 RENAL FAILURE | 6 0.06 87.73 RENAL FAILURE CHRONIC | 26 0.26 87.99 RENAL IMPAIRMENT | 1 0.01 88.00 RENAL TRANSPLANT | 63 0.63 88.63 RESORPTION BONE INCREASED | 1 0.01 88.64 RESPIRATORY DEPRESSION | 1 0.01 88.65 RESPIRATORY DISORDER | 4 0.04 88.69 RESPIRATORY THERAPY | 1 0.01 88.70 RESPIRATORY TRACT CONGESTION | 1 0.01 88.71 RESTLESS LEGS SYNDROME | 37 0.37 89.08 RESTLESSNESS | 3 0.03 89.11 RETINAL HAEMORRHAGE | 2 0.02 89.13 RETINAL NEOVASCULARISATION | 1 0.01 89.14 RETINAL VEIN OCCLUSION | 1 0.01 89.15 RHEUMATOID ARTHRITIS | 273 2.73 91.88 RHINITIS ALLERGIC | 4 0.04 91.92 RHINORRHOEA | 1 0.01 91.93 ROTATOR CUFF SYNDROME | 1 0.01 91.94 SALIVARY HYPERSECRETION | 1 0.01 91.95 SARCOMA | 5 0.05 92.00 SCAN WITH CONTRAST | 1 0.01 92.01 SCAR PAIN | 1 0.01 92.02 SCHIZOAFFECTIVE DISORDER | 18 0.18 92.20 SCHIZOPHRENIA | 44 0.44 92.64 SCHIZOPHRENIA, CATATONIC TYPE | 3 0.03 92.67 SCHIZOPHRENIA, DISORGANISED TYPE | 1 0.01 92.68 SCHIZOPHRENIA, PARANOID TYPE | 13 0.13 92.81 SCIATICA | 2 0.02 92.83 SCRUB TYPHUS | 1 0.01 92.84 SEASONAL ALLERGY | 7 0.07 92.91 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 4 0.04 92.95 SEDATION | 18 0.18 93.13 SEDATIVE THERAPY | 7 0.07 93.20 SELECTIVE IGA IMMUNODEFICIENCY | 1 0.01 93.21 SENSITIVITY OF TEETH | 1 0.01 93.22 SEPSIS | 27 0.27 93.49 SEPTIC SHOCK | 1 0.01 93.50 SERONEGATIVE ARTHRITIS | 2 0.02 93.52 SHUNT THROMBOSIS | 2 0.02 93.54 SICKLE CELL ANAEMIA | 1 0.01 93.55 SINOBRONCHITIS | 2 0.02 93.57 SINUS CONGESTION | 2 0.02 93.59 SINUS DISORDER | 1 0.01 93.60 SINUSITIS | 6 0.06 93.66 SKIN CANCER | 1 0.01 93.67 SKIN COSMETIC PROCEDURE | 1 0.01 93.68 SKIN INFECTION | 3 0.03 93.71 SKIN WRINKLING | 1 0.01 93.72 SLEEP APNOEA SYNDROME | 2 0.02 93.74 SLEEP DISORDER | 22 0.22 93.96 SLEEP DISORDER THERAPY | 3 0.03 93.99 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 8 0.08 94.07 SMOKING CESSATION THERAPY | 160 1.60 95.67 SOMATOFORM DISORDER | 3 0.03 95.70 SOMNOLENCE | 2 0.02 95.72 SPINAL ANAESTHESIA | 1 0.01 95.73 SPINAL COLUMN STENOSIS | 2 0.02 95.75 SPINAL FRACTURE | 2 0.02 95.77 SPINAL OSTEOARTHRITIS | 1 0.01 95.78 SPLENECTOMY | 1 0.01 95.79 SPONDYLITIS | 5 0.05 95.84 SQUAMOUS CELL CARCINOMA | 2 0.02 95.86 SQUAMOUS CELL CARCINOMA OF SKIN | 1 0.01 95.87 SQUAMOUS CELL CARCINOMA OF THE CERVIX | 3 0.03 95.90 STAPHYLOCOCCAL BACTERAEMIA | 3 0.03 95.93 STAPHYLOCOCCAL INFECTION | 7 0.07 96.00 STATUS ASTHMATICUS | 1 0.01 96.01 STATUS EPILEPTICUS | 5 0.05 96.06 STENT PLACEMENT | 3 0.03 96.09 STEROID THERAPY | 2 0.02 96.11 STEROID WITHDRAWAL SYNDROME | 1 0.01 96.12 STOMACH DISCOMFORT | 4 0.04 96.16 SUICIDAL IDEATION | 1 0.01 96.17 SUICIDE ATTEMPT | 5 0.05 96.22 SUPPLEMENTATION THERAPY | 6 0.06 96.28 SUPRAVENTRICULAR TACHYCARDIA | 2 0.02 96.30 SURGERY | 4 0.04 96.34 SWEAT GLAND INFECTION | 1 0.01 96.35 SWELLING | 1 0.01 96.36 SYSTEMIC ANTIBACTERIAL THERAPY | 9 0.09 96.45 SYSTEMIC CANDIDA | 3 0.03 96.48 SYSTEMIC LUPUS ERYTHEMATOSUS | 6 0.06 96.54 SYSTEMIC MYCOSIS | 3 0.03 96.57 T-CELL LYMPHOMA | 7 0.07 96.64 T-CELL PROLYMPHOCYTIC LEUKAEMIA | 2 0.02 96.66 TACHYCARDIA | 1 0.01 96.67 TENDONITIS | 1 0.01 96.68 TESTIS CANCER | 4 0.04 96.72 THERAPEUTIC SKIN CARE TOPICAL | 1 0.01 96.73 THERMAL BURN | 2 0.02 96.75 THROMBOCYTHAEMIA | 1 0.01 96.76 THROMBOCYTOPENIA | 2 0.02 96.78 THROMBOLYSIS | 1 0.01 96.79 THROMBOPHLEBITIS | 1 0.01 96.80 THROMBOSIS | 4 0.04 96.84 THROMBOSIS PROPHYLAXIS | 32 0.32 97.16 THROMBOTIC STROKE | 1 0.01 97.17 THYROID CANCER | 1 0.01 97.18 THYROID DISORDER | 8 0.08 97.26 THYROID THERAPY | 1 0.01 97.27 THYROTOXIC CRISIS | 2 0.02 97.29 TINEA INFECTION | 5 0.05 97.34 TOBACCO ABUSE | 3 0.03 97.37 TOBACCO USER | 1 0.01 97.38 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 1 0.01 97.39 TONSIL CANCER | 3 0.03 97.42 TONSILLAR DISORDER | 3 0.03 97.45 TOOTH ABSCESS | 5 0.05 97.50 TOOTH DISORDER | 2 0.02 97.52 TOOTH INFECTION | 3 0.03 97.55 TOOTHACHE | 4 0.04 97.59 TORTICOLLIS | 2 0.02 97.61 TOURETTE'S DISORDER | 3 0.03 97.64 TOXIC SHOCK SYNDROME | 3 0.03 97.67 TRACHEAL DISORDER | 1 0.01 97.68 TRANSGENDER HORMONAL THERAPY | 1 0.01 97.69 TRANSIENT ISCHAEMIC ATTACK | 3 0.03 97.72 TRANSIENT PSYCHOSIS | 1 0.01 97.73 TRANSITIONAL CELL CARCINOMA | 4 0.04 97.77 TRANSPLANT | 4 0.04 97.81 TRAUMATIC HAEMORRHAGE | 3 0.03 97.84 TREATMENT FAILURE | 1 0.01 97.85 TREMOR | 5 0.05 97.90 TRICHOTILLOMANIA | 1 0.01 97.91 TRIGEMINAL NEURALGIA | 5 0.05 97.96 TUBERCULIN TEST | 1 0.01 97.97 TUBERCULOSIS | 10 0.10 98.07 TUBERCULOSIS SKIN TEST POSITIVE | 1 0.01 98.08 TUBERCULOUS PLEURISY | 1 0.01 98.09 TYMPANIC MEMBRANE PERFORATION | 1 0.01 98.10 TYPE 1 DIABETES MELLITUS | 19 0.19 98.29 TYPE 2 DIABETES MELLITUS | 59 0.59 98.88 TYPE IIA HYPERLIPIDAEMIA | 1 0.01 98.89 ULCER | 1 0.01 98.90 UNEVALUABLE EVENT | 17 0.17 99.07 UPPER RESPIRATORY TRACT INFECTION | 1 0.01 99.08 UPPER RESPIRATORY TRACT INFLAMMATION | 3 0.03 99.11 URAEMIC PRURITUS | 1 0.01 99.12 URETERIC CANCER | 1 0.01 99.13 URETHRITIS | 1 0.01 99.14 URINARY INCONTINENCE | 4 0.04 99.18 URINARY RETENTION | 1 0.01 99.19 URINARY TRACT INFECTION | 12 0.12 99.31 URTICARIA | 4 0.04 99.35 UTERINE CANCER | 2 0.02 99.37 UTERINE HAEMORRHAGE | 1 0.01 99.38 UVEITIS | 3 0.03 99.41 VAGINAL ABSCESS | 1 0.01 99.42 VAGINAL HAEMORRHAGE | 1 0.01 99.43 VAGINAL INFECTION | 1 0.01 99.44 VARICOSE ULCERATION | 1 0.01 99.45 VARICOSE VEIN OPERATION | 2 0.02 99.47 VASCULAR HEADACHE | 1 0.01 99.48 VENOUS THROMBOSIS | 2 0.02 99.50 VENOUS THROMBOSIS LIMB | 1 0.01 99.51 VENTRICULAR ASSIST DEVICE INSERTION | 1 0.01 99.52 VENTRICULAR TACHYCARDIA | 3 0.03 99.55 VERTIGO | 1 0.01 99.56 VIRAL INFECTION | 3 0.03 99.59 VISUAL ACUITY REDUCED | 1 0.01 99.60 VITAMIN B1 | 1 0.01 99.61 VITAMIN D DEFICIENCY | 1 0.01 99.62 VITAMIN SUPPLEMENTATION | 10 0.10 99.72 VOMITING | 4 0.04 99.76 VULVAL CANCER | 1 0.01 99.77 VULVOVAGINAL DRYNESS | 1 0.01 99.78 WALDENSTROM'S MACROGLOBULINAEMIA | 1 0.01 99.79 WEGENER'S GRANULOMATOSIS | 2 0.02 99.81 WEIGHT CONTROL | 2 0.02 99.83 WEIGHT DECREASED | 2 0.02 99.85 WEIGHT LOSS DIET | 6 0.06 99.91 WHEEZING | 5 0.05 99.96 WOUND | 1 0.01 99.97 WOUND INFECTION | 1 0.01 99.98 YOLK SAC TUMOUR SITE UNSPECIFIED | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015